首页> 外国专利> Sibutramine and orlistat (xenical) used either simultaneously, separately or sequentially to treat obesity

Sibutramine and orlistat (xenical) used either simultaneously, separately or sequentially to treat obesity

机译:西布曲明和奥利司他(xenical)可同时,分别或依次用于治疗肥胖

摘要

A method for the treatment of obesity in a human comprising administration of a therapeutically effective amount of a compound of formula I, including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula II wherein the compound of formula I and the compound of formula II are administered simultaneously, separately or sequentially.
机译:一种治疗人的肥胖症的方法,包括给予治疗有效量的式I化合物,包括对映体及其药学上可接受的盐,其中R 1和R 2独立地为H或甲基,以及治疗有效量的式I化合物式II化合物,其中式I化合物和式II化合物同时,分别或依次给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号